Curriculum Vitae

PERSONAL DETAILS

PROF. DR. ANITA ZARINA BINTI BUSTAM @ MAINUDIN

  • Professor

  • Faculty of Medicine Dean's Office
    Faculty of Medicine
  •    +603-79492185
  •   anitabustam@um.edu.my

ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • National Project Coordinator, International, 30/01/2018 to present
  • JKKF Committee member, University Malaya, 06/04/2017 to 05/04/2020
  • HRPP Committee member, Faculty, 02/05/2017 to 01/05/2019
  • Programme Coordinator, University Malaya, 02/09/2016 to 01/09/2017
  • Quality Manager, University Malaya, 04/07/2016 to 03/07/2017
  • AJK Penulisan Kurikulum Nasional Sarjana Perubatan Klinikal bagi bidang Onkologi Klinikal, National, 01/01/2016 to present
  • Programme Coordinator, Faculty, 01/09/2014 to 01/09/2016
  • Quality Manager, Faculty, 01/07/2014 to 01/07/2016
  • Postgraduate Curriculum Working Group, Faculty, 23/09/2014 to present
  • Head, UNIVERISITI MALAYA, 01/09/2012 to 31/08/2013
  • Ahli Jawatankuasa PPGP, Faculty, 01/10/2013 to present
  • Head Coordinator, Faculty, 01/10/2002 to 31/08/2013
  • Head of Department, Faculty, 01/08/2000 to 31/08/2013
  • National Project Coordinator for IAEA project RAS6040, National, 01/01/2005 to 31/12/2009
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • FRCR(UK)(2000), RADIOTHERAPHY & ONCOLOGY, ROYAL COLLEGE OF RADIOLOGIST, LONDON
  • MBBS(CARDIFF)(1992), MEDICINE AND SURGERY, UNIVERSITY OF WALES COLLEGE OF MEDICINE, CARDIFF
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • SEAROG, Advisor, 2019 to 2019 (International)
  • FARO, Council Member, 2019 to 2019 (International)
SPECIALIZATION
(Area)
Area of Expertise
  • Clinical Oncology which covers all aspects of non-surgical treatment modalities for cancer patients in particular with radiotherapy, cytotoxics, hormones and biologics. Tumour site specialization includes breast,lung, brain, lymphoproliferative tissue, paediatrics and skin.
  • Research Interest
  • Clinical trials any solid tumour in particular breast cancer.
  • TEACHING
    (Course Title),(Level of Study),(Institution),(Academic Session)
    Teaching
  • - Master of Clinical Oncology Part 2 Clinical Teaching, Master, University of Malaya (2021/2)
  • UMMP - , First Degree, UNIVERSITY MALAYA (2018/2019)
  • UMMP - , First Degree, UNIVERSITY MALAYA (2018/2019)
  • MAGT - , Post Graduate, UNIVERSITY MALAYA (2018/2019)
  • UMMP - Ummp, First Degree, UNIVERSITY MALAYA (2018/2019)
  • MAGT6300 - Magt6300, Post Graduate, UNIVERSITY MALAYA (2019/2020)
  • MAGT - , Post Graduate, UNIVERSITY MALAYA (2019/2020)
  • MAGT - , Post Graduate, UNIVERSITY MALAYA (2020/2021)
  • MAGT6300 - Magt6300, Post Graduate, UNIVERSITY MALAYA (2020/2021)
  • MAGT6300 - Magt6300, Post Graduate, UNIVERSITY MALAYA (2020/2021)
  • MID2005 - Basic Medical Science Iii, First Degree, UNIVERSITY MALAYA (2020/2021)
  • ummp - , First Degree, UNIVERSITY MALAYA (2020/2021)
  • UMMP - , First Degree, UNIVERSITY MALAYA (2020/2021)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2017/2018)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2011/2012)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2012/2013)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2013/2014)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2012/2013)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2014/2015)
  • Ummp, First Degree, UNIVERSITY MALAYA (2014/2015)
  • ONCOLOGY - Ummp, First Degree, UNIVERSITY MALAYA (2015/2016)
  • Ummp, First Degree, UNIVERSITY MALAYA (2015/2016)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2015/2016)
  • ONCOLOGY - Ummp, First Degree, UNIVERSITY MALAYA (2015/2016)
  • Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2015/2016)
  • UMMP - Ummp, First Degree, UNIVERSITY MALAYA (2016/2017)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2016/2017)
  • ONCOLOGY - Ummp, First Degree, UNIVERSITY MALAYA (2016/2017)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2016/2017)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2011/2012)
  • Basec Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2002/2003)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2006/2007)
  • Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2003/2004)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2006/2007)
  • ADNS - Advanced Diploma in Nursing (Oncology), UNIVERSITY MALAYA (2006/2007)
  • Basic Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2006/2007)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2006/2007)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2007/2008)
  • UMMP - , First Degree, UNIVERSITY MALAYA (2020/2021)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2000/2001)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2008/2009)
  • Diploma in Radiography, Diploma (If Applicable), UNIVERSITY MALAYA (2001/2002)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2005/2006)
  • Basic Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2004/2005)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2005/2006)
  • Diploma in Radiography, Diploma (If Applicable), UNIVERSITY MALAYA (2004/2005)
  • Diploma in Radiography, Diploma (If Applicable), UNIVERSITY MALAYA (2004/2005)
  • Master of Internal Medicine, Post Graduate, UNIVERSITY MALAYA (2004/2005)
  • ADNS - Advanced Diploma in Nursing (Oncology), UNIVERSITY MALAYA (2004/2005)
  • Master of Obstetrics & Gynaecology, Post Graduate, UNIVERSITY MALAYA (2004/2005)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2004/2005)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2004/2005)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2009/2010)
  • Advanced Diploma in Nursing (Oncology), UNIVERSITY MALAYA (2003/2004)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2005/2006)
  • Master of Otorhinolaryngology, Post Graduate, UNIVERSITY MALAYA (2005/2006)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2003/2004)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2004/2005)
  • Basic Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2003/2004)
  • NA - Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2003/2004)
  • Diploma in Radiography, Diploma (If Applicable), UNIVERSITY MALAYA (2003/2004)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2010/2011)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2002/2003)
  • Diploma in Radiography, Diploma (If Applicable), UNIVERSITY MALAYA (2002/2003)
  • ADNS - Advanced Diploma in Nursing (Oncology), UNIVERSITY MALAYA (2008/2009)
  • Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2002/2003)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2002/2003)
  • Mbbs, First Degree, UNIVERSITY MALAYA (2001/2002)
  • Basic Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2007/2008)
  • Basic Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2001/2002)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2001/2002)
  • Diploma in Radiography, Diploma (If Applicable), UNIVERSITY MALAYA (2000/2001)
  • MAGT - Master of Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2007/2008)
  • Master of Medical Physics, Post Graduate, UNIVERSITY MALAYA (2000/2001)
  • Basic Degree in Nursing Sciences, First Degree, UNIVERSITY MALAYA (2000/2001)
  • PUBLICATIONS
    (Title of publication in APA style)
    Refereed Journals
    2019
    • Survival of oral cancer patients in different ethnicity (ISI-Indexed)
    • Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early-stage HER2-positive breast cancer (ISI-Indexed)
    2018
    • Syadwa Abdul Shukor, Anita Zarina Bustam, Palliative radiotherapy for advanced Cancer: Are we giving it to the right patient at the right time?Med J Malaysia Vol 73 No 4 August 2018 (SCOPUS-Indexed)
    2017
    • Rosenblatt, E.,Prajogi, G. B., Barton, M., Fidarova, E.,Eriksen, J. G., Haffty, B., Millar, B. A.,Bustam,A., Zubizarreta, E., & Abdel-Wahab,M. (2017). Need for Competency-Based Radiation Oncology Education in Developing Countries. Creative Education, 8, 66-80. (ISI-Indexed)
    • Miguel Martin, MD et al. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology Nov 13, 2017 (ISI-Indexed)
    • Moradi, F., Ung, N.M., Khandaker, M.U., Mahdiraji, G.A., SAAD, M., Malik, R.A., Bustam, A.Z., Zaili, Z. and Bradley, D.A.,(2017). Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators. Physics in medicine and biology. 62, 6550-66. (ISI-Indexed)
    2016
    • The challenges of treating childhood medulloblastoma in a country with limited resources: 20 years experience at a single tertiary centre in Malaysia. Journal of Global Oncology, 2016 (Non-ISI/Non-SCOPUS)
    2015
    • Chandramathi S, Suresh K, Anita ZB, Rokiah P, Kuppusamy UR. Urinary Advanced Oxidation Protein Product (AOPP): A Potential Oxidation Damage Marker for Cancer . West Indian Medical Journal, In press. (ISI-Indexed)
    • Yahaya NA1, Subramanian P, Bustam AZ, Taib NA.2015.Symptom Experiences and Coping Strategies among Multi- ethnic Solid Tumor Patients Undergoing Chemotherapy in Malaysia.Asian Pac J Cancer Prev 16(2):723-30. (ISI-Indexed)
    • Vincent Chee Ee Phua, Wei Quan Wong, Pei Lin Tan, Anita Zarina Bustam, MARNIZA SAAD, Adlinda Alip, Wan Zamaniah Wan Ishak. Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice (ISI-Indexed)
    2013
    • Nor Zuraida Zainal, Norley Shuib, Anita Zarina Bustam, Zuraida Ahmad Sabki, Ng Chong Guan. 2013. Reliability and Validity of the Malay Version of the Breast-Impact of Treatment Scale (MVBITS) in Breast Cancer Women undergoing Chemotherapy. Asian Pacific J Cancer Prev, 14 (1), 463-468 (ISI-Indexed)
    • Zain RB, Athirajan V, Ghani WM, Razak IA, Raja Latifah RJ, Ismail SM, Sallam AA, Bustam AZ, Rahman ZA, Hussien A, Talib N, Cheong SC, Jallaludin A.2013 An oral cancer biobank initiative: a platform for multidisciplinary research in a developing country. Cell Tissue Bank. 14(1):45-52 (ISI-Indexed)
    2012
    • Phua Chee Ee, Anita Zarina Bustam,Mastura Md Yusof, MARNIZA SAAD,Yip Cheng-Har, Nor Aishah Taib, Ng Char Hong, Teh Yew Ching 2012. Risk of Treatment Related Death and Febrile Neutropaenia with Taxane-Based Adjuvant Chemotherapy for Breast Cancer in a Middle Income Country Outside a Clinical Trial Setting. Asia Pacific Journal of Cancer Prevention; 13(9), 4623-4626. (ISI-Indexed)
    • Chee Ee Phua, Anita Zarina Bustam, Mastura Md Yusof, MARNIZA SAAD, Cheng-Har Yip, Nor Aishah Taib and Char Hong Ng. 2012 Risk of treatment related death (TRD) with adjuvant chemotherapy for breast cancer: A study in University Malaya Medical Centre (UMMC). Journal of Cancer Therepeutics & Research 1: 13 (SCOPUS-Indexed)
    2011
    • Chandramathi S,Suresh K,Anita ZB,Kuppusamy UR (2011). Infection of Blastocystis hominis and microsporidia: are they opportunistic? Trans. R. Soc. Trop. Med. Hyg. (ISI-Indexed)
    2010
    • Seriramalu R, Pang W, Jayapalan JJ, Mohamed E, Abdul- Rahman PS, Bustam AZ, Khoo ASB, Hashim OH;Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasked reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis 31:14, 2388-2395 Jul 2010 (ISI-Indexed)
    • Lau Peng Choong, Nur Aishah Mohd Taib, Sanjay Rampal, Marniza Saad, Anita Zarina Bustam, Yip Cheng Har; High Tumour Stage and Margin Clearance are still important prognostic factors for post-mastectomy locoregional recurrence in Malaysia; Asian Pacific Journal for Cancer Prevention,11,1409-1416 Dec 2010 (ISI-Indexed)
    • Shingo Kato, Tatsuya Ohno, Kullathorn Thephamongkol, Yaowalak Chansilpa, Yang Yuxing, C.R.Beena Devi, Anita Z. Bustam, Miriam J.C. Calaguas, Rey H. De Los Reyes, Chul-Koo Cho, To Anh Dung, Nana Supriana, Hideyuki Mizuno, Takashi Nakano, Hirohiko Tsujii. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia. Int J Radiation Oncology Biol Phys Vol 77 No 3 pg 751-757, 2010 (ISI-Indexed)
    • Hoong-Yin Chong, Nur Aishah Taib, Sanjay Rampal, Marniza Saad, Anita Zarina Bustam, Cheng-Har Yip. Treatment options for locally advanced breast cancer - experience in an Asian tertiary hospital. APJCP, 11:2010;1-5. (ISI-Indexed)
    • Prognostic Factors for Elderly Breast Cancer Patients in University Malaya Medical Centre, Malaysia CE Phua1*, AZ Bustam2, Cheng-Har Yip3, Nor Aishah Taib3 2010 Asian Pacific J Cancer Prev, 11, 1205-1211 (ISI-Indexed)
    2009
    • S.Chandramathi,K.Suresh,Z.B.Anita,U.R.Kuppusamy. Elevated levels of urinary hydrogen peroxide, advanced oxidative protein product (AOPP) and malonaldehyde in humans infected with intestinal parasites.Cambridge University Press. Parasitology (2009) 136, 359-363 (ISI-Indexed)
    • S. Chandramathi, K. Suresh, Z. B. Anita, U. R. Kuppusamy. Attenuation of serum H2O2 and FRAP levels in colorectal cancer patients with intestinal parasitic infection. Mal J Med Sci (2009) 16(2), 15-20 (SCOPUS-Indexed)
    2008
    • Emida Mohamed1 ,Puteri Shafinaz Abdul-Rahman1, Saeid Reza Doustjalali1,Yeng Chen1, Boon-Kiong Lim2, Siti Zawiah Omar2, Anita Zarina Bustam3, Vivek Ajit Singh4, Nur Aishah Mohd-Taib5, Cheng-Har Yip5, Onn Haji Hashim1.1Dept of Molecular Medicine, 2Dept. Of Obstetrics and Gynaecology, 3Clinical Oncology Unit, 4Dept. Of Orthopaedic Surgery, 5Dept. Of Surgery, Faculty of Medicine, University of Malaya. Lectin- based electrophoretic analysis of the expression of the 35 kDa inter- - trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies. 2008, 29, 2645-2650 (ISI-Indexed)
    • S.Chandramathi,K.Suresh,Z.B. Anita,U.R.Kuppusamy. Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. J cancer Res Clin Oncol (2009) 135:319-325 Published online 29 Aug 2008 (ISI-Indexed)
    2007
    • Nor ZAINAL, Koh HUI, Ting HANG and Anita BUSTAM. Department of Psychological Medicine and Clinical oncology Unit, Faculty of Medicine, Universiti Malaya. Prevalence of distress in cancer patients undergoing chemotherapy. Asia Pacific Journal of Clinical Oncology 2007; 3: 219-223 (Full paper) (ISI-Indexed)
    2006
    • Saeid R. Doustjali, Rohana Yusof, Gopala K. Govindasamy, Anita Z. Bustam, Bhanumathy Pillay, and Onn H. Hashim. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. The Journal of Medical Investigation Vol. 53 No. 1,2, February, 2006 (Full paper) (SCOPUS-Indexed)
    • Kei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, Santai Song, Reena Nair, Corazon A. Ngelangel, Anita Bustam, William H.H Reece, Manfred Lehnert.Gemcitabine and split dose paclitaxel or docetaxel in metastatic breast cancer: a randomized phase II study. European Journal of Cancer 42 (2006) 1797-1806 (Full paper) (ISI-Indexed)
    2005
    • R.B. Zain, Raja Latifah RJ, Razak IA, Ismail SM, Atiya SA, Hashim BY, Jallaludin A, Bustam AZ, Rahman ZAA, Krishnan G, Kipli NP, Samsudin AR, Nasir WM, Mahadzir WMW, Abraham MT, Norma J, Tay KK, Yuen KM, Cheong SC and Other MOCRI team members. Oral cancer and Precancer in Malaysia The Database and Tissue Resource Bank. Oral Oncology, MacMillan India; 2005. Vol 10: 3-12 (Full paper) (Non-ISI/Non-SCOPUS)
    • Si Lay Khaing, V Sivaratnam, Siti Zawiah Omar, Anita Zarina Bustam, Mun Kein Seong. Case Report: Small cell carcinoma of uterine cervix in a teen-aged girl a rare occurrence. Malaysian Journal of Obstetrics & Gynaecology 2005: Vol. 8 No. 9: 62-67 (Full paper) (Non-ISI/Non-SCOPUS)
    Article in Proceeding
    2006
    • Pawanchek M, Ung N-M*, Bustam A* and Ng K-H. Department of Biomedical Imaging, University of Malaya, *Clinical Oncology Unit, University of Malaya. In-vivo skin dose assessment for breast cancer during radiotherapy treatment using gafchromic film (EBT) detector. Proceedings 29th Annual General Meeting & Scientific Meeting of the College of Radiology Malaysia 3-4 June 2006. (Abstract)
    2005
    • 5.R.B. Zain, R.J. Raja Latifah, I.A. Razak, S.M. Ismail, A.R. Samsuddin, S.A. Atiya, B.Y. Hashim, A. Jallaludin, W.M. Nasir, S.C. Cheong, A.Z.Bustam, W.M.W. Mahadzir, M.T.Abraham, Z.A.A. Rahman, G. Krishnan, N.P. Kipli, J. Norma, K.K. Tay, K.M. Yuen and other MOCRI Team Members. University of Malaya, Universiti Sains Malaysia, Ministry of Health Malaysia, Cancer Research Initiatives Foundation, Malaysia. Oral cancer and precancer research in Malaysia-the database and tissue resource bank. Proceedings of the 10th International Congress on Oral cancer, 19-24th April 2005, Island of Crete, Greece. Oral Oncology Supplement; April 2005; Vol 1 No 1; pp 123 (Abstract)
    2004
    • K.-S. Khoo, M. Zaidi, V. Srimuninnimit, Z. F. Jiang, P. Prem Kumar, A. Bustam, A. H. Villalon, M. Lehnert; National Cancer Centre, Singapore;Baquai Institute of Oncology, Karachi, Pakistan; Siriraj Hospital, Mahidol University, Bangkok, Thailand; 307 Hospital, Academy of Military Medical Sciences, Beijing, China; MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; University Malaya Medical Centre, Kuala Lumpur, Malaysia; Manila Doctors Hospital, Manila, Philippines; Eli Lilly Asian Operations Ltd, Hong Kong, China.Randomized phase II trial of three gemcitabine (GEM)-taxane combinations in metastatic breast cancer (MBC). Vol. 23, 2004 American Society of Clinical Oncology Meeting Proceedings- (Abstract)
    2001
    • Abdul Wahid, A Bustam, F Hayat P Rassiah and U Prasad.Re-treatment of 14 patients with recurrent nasopharyngeal carcinoma using CT simulation and conformal therapy. Radiotherapy and Oncology, Vol. 58 (Supplement1) pg.S97, 6th International Congress of Radiation Oncology Melbourne, Aus, Jan/Feb 2001- (Abstract)
    Others
    2003
    • National Clinical Practice Guideline for Breast Cancer Published by MOH/Academy of Medicine Launched in September 2003 - -
    2001
    • Radiation Therapy of Stage IIIB Cervical cancer for Asians Report and Guideline from the Cooperative Group Trial. Published by Asia Cooperation Center, Japan Atomic Industrial Forum, Inc. Launched in September 2001 - -
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    International Funding
  • TROIKA study. Neoadj and adjuvant trastuzumab vs biosimilar in HER 2 positive EBC, Principal Investigator(PI), 2018 - 2023 (International)
  • MSD
  • MK3475-355 A Randomized, Double-Blind Phase III Study of Pembrolizumab (MK-3475) plus Chemotherapy vs Placebo plus Chemotherapy for Previously Untreated Inoperable Locally Recurrent or Metastatic Triple Negative Breast Cancer - (KEYNOTE-355), Principal Investigator(PI), 2016 - 2019 (International)
  • A randomised open label phase 3 study of single agent pembrolizumab vs single agent chemo per physician's choice for metastatic triple negative breast cancer-[KEYNOTE-119 study], Principal Investigator(PI), 2015 - 2018 (International)
  • NUS
  • A Prospective Cohort Study of Patients with Malignant Cord Compression , Consultant, 2014 - 2015 (International)
  • Samsung Bioepis
  • A Phase III Randomised, Double-Blind,Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin in Women with Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting , Consultant, 2014 - 2016 (International)
  • NONE
  • Prospective study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics and pharmacodynamics in Asian women with hormone receptor-positive advanced breast cancer , Consultant, 2013 - 2015
  • Phase II randomized study of docetaxel with or without low-dose, short course sunitinib in the treatment of advanced solid tumors. , Consultant, 2013 - 2015
  • Roche
  • JACOB study:A Double-Blind, Placebo-Controlled, Randomized, Multicenter Phase III Study Evaluating The Efficacy and Safety of Pertuzumab in Combination with Trastuzumab and Chemotherapy in Patient with HER-2 Positive Metastatic Gastroesophageal Junction and Cancer , Principal Investigator(PI), 2013 - 2015 (National)
  • A Phase 2 Biomarker identification Trial for Erlotinib in patients with Advanced Pancreatic carcinoma (MARK study) , Principal Investigator(PI), 2008 - 2011 (International)
  • SATURN/TITAN- A Multicentre, double blind randomized phase 3 study to evaluate the efficacy of Tarceva or placebo following 4 cycles of platinum-based chemotherapy in patients with histologically documented or advanced or recurrent or metastatic NSCLC who have not experienced disease progression or unacceptable toxicity during chemotherapy , Principal Investigator(PI), 2006 - 2011 (International)
  • Quintiles Janseen Cilaq
  • ABI-PRO- 3002 A phase 3, randamized, double-blind,placebo-controlled study of abiraterone acetate)JNJ-212082) plus prednisone in asymtomic ormildly symptomatic patients with metastaticcastration-resistant prostate cancer, Consultant, 2012 - 2017 (National)
  • High Impact Research (HIR)
  • Lapatinib study Phase II open-labelstudy of preoperativeweeklypac55 litaxel and carboplatinwithlapatinib (Tykerb ) in patientswith ErB2-positive stage I-III Breastc ncer , Consultant, 2011 - 2013
  • Biobanking of Oral Cancers: An Assessment of Survival, Clinicopathological Parameters, Management Strategies Nutrition and Genetic Susceptibility of Patients , Consultant, 2011 - 2016
  • Pfizer
  • Phase 3 open label first line treatment for HER2 positive breast cancer comparing Paclitaxel plus herceptin vs Paclitaxel plus Neratinib. , Consultant, 2010 - 2016 (International)
  • HKI 3004 Adjuvant breast cancer study in HER2 positive patients using neratinib. , Principal Investigator(PI), 2010 - 2016 (International)
  • AGILE Axitinib in metastatic renal cell carcinoma patients. , Consultant, 2010 - 2015 (International)
  • 2009AG-013736 (Axitinib) as Second Line Therapy for Asian Patients with Metastatic Renal Cell Cancer , Consultant, 2009 - 2011 (International)
  • A multinational, randomised, open-label, phase 3 study of sunitinib malate vs sorafenib in patients with advanced hepatocellular carcinoma. , Consultant, 2008 - 2011 (International)
  • Amgen
  • D- CARE A Randomised Double- Blind, Placebo- Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence , Principal Investigator(PI), 2010 - 2020 (International)
  • ASPECCT Panitumumab vs cetuximab for the third line treatment of advanced colorectal cancer. , Consultant, 2010 - 2012 (International)
  • Postgraduate Research Grant(PPP)
  • The Establishment of In-vitro Standard Dose Calibration Curve with High Energy X-ray and Measurement of The Equivalent Dose In Cancer Patients Treated with Radiotherapy Using Biological Dosimetry Technique, Principal Investigator(PI), 2010 - 2011 (National)
  • NCC Singapore
  • ASCOLT Aspirin in treating patients with Dukes stage C colon or rectal cancer, or high risk Dukes stage B colon cancer that has been completely removed by surgery., Consultant, 2010 - 2026 (International)
  • Boehringer-Ingelheim
  • LUME-Lung 2 An international, multi-centre phase III randomised controlled trial for second line treatment of recurrent, advanced non-small cell lung cancer, comparing pemetrexed + placebo versus pemetrexed + BIBF1120 (a multi-targeted tyrosine kinase inhibitor). , Principal Investigator(PI), 2009 - 2012 (International)
  • Wyeth
  • An international multi-centre phase III randomised controlled trial of first line treatment of advanced renal cell carcinoma, comparing bevacizumab + interferon-alpha versus bevacizumab + torisel. , Consultant, 2008 - 2012
  • Phase 3b, randomised, open-label study of Bevacizumab + Temsirolimus vs Bevacizumab + Interferon-alfa as first-line treatment in subjects with advanced renal cell carcinoma. , Consultant, 2008 - 2012 (International)
  • Genentech
  • BEATRICE , Principal Investigator(PI), 2008 - 2014 (International)
  • A phase 3 multicentre, randomised, placebo- controlled trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy regimens in subjects with previously treated metastatic breast cancer. , Consultant, 2007 - 2010
  • Short Term Research Fund (Vote F)(PJP)
  • A prospective controlled study on the role of Scalp Hypothermia to prevent chemotherapy-induced Alopecia in patients with breast cancer receiving anthRacycline and taxanE-based chemotherapy. (SHARE Study) , Consultant, 2008 - 2010 (National)
  • Geran Penyelidikan Universiti Malaya (UMRG)
  • Induction and concurrent chemoradiation with cetuximab for treatment of locally advanced Nasopharyngeal Carcinoma , Consultant, 2008 - 2012 (National)
  • A Prospective controlled study on the role of Scalp Hypothermia to prevent chemotherapy-induced Alopecia in patients with breast cancer receiving anthRacycline and taxanE-based chemotherapy (SHARE Study) , Consultant, 2008 - 2010 (National)
  • GSK
  • A Phase II, Open-label, Randomised, Multicenter Trial of GW786034 (Pazopanib) in combination with Lapatinib (GW 572016) compared to Lapatinib alone as first line therapy in subjects with advanced or metastatic breast cancer with erb-B2 FISH positive tumours. , Consultant, 2007 - 2008 (International)
  • Phase II, open label study of SB-715992 in subjects with advanced or metastatic breast cancer. , Consultant, 2004 - 2008 (International)
  • MOH
  • A multi-institutional study on the clinical outcome of patients with nasopharyngeal carcinoma (NPC) and the establishment of a Malaysian NPC tissue bank. , Consultant, 2007 - 2008 (National)
  • ScienceFund
  • Development of Risk Models and Management Strategies for Oral Cancer , Consultant, 2007 - 2015 (National)
  • BMS
  • A Phase III trial of novel Epothilone BMS-247550 plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant., Principal Investigator(PI), 2005 - 2008 (International)
  • IRPA
  • Oral cancer and precancer in Malaysia-risk factors, prognostic markers, genetic expression and impact on quality of life. , Consultant, 2004 - 2015 (National)
  • FNCA, Japan
  • Concurrent weekly Cisplatin and radiotherapy for advanced cervical cancer. , Consultant, 2003 - 2008 (International)
  • Eli Lilly
  • Randomised Phase 2 trial of Gemcitabine combined with a Taxane for metastatic breast cancer. , Principal Investigator(PI), 2001 - 2003 (International)
  • SUPERVISION
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Ongoing
    • clinical supervision, Tan Li Mei, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Jasmin Munchar, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nor Faizah Abd Muin, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Tang Shir Ley, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Daniel Gan, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Liew Zhi Hao, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Chen May Feng, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Anbarasan Anbazagan, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Mohd Fahim Abd Rahman, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Shazlin Hasbullah, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Jason Lai Shen Chang, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Shazlin Md Hasbullah, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Mohd Fahim Abd Rahman, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Fatimahtulzahrah saparmin, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Sum Ying Ying, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Jason Lai Shen Chang, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Tun Mohd Azlan Mohd Nor, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Rufus Jesudas, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nor Hayati Hashim, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Tun Mohd Azlan Mohd Nor, University of Malaya (UM) (Post Graduate Student)
    • Cancer Trend, Utilisation of Resources and Workload Analysis at a Tertiary Academic Hospital in a Developing Country, Daniel Gan Eng Hwee, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Nor Hayati Hashim, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Magdalene Anuth Ranjit, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Chan Ming Jun, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nadiah Zainal, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nurul Iman Fathi, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Sum Ying Ying, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Chiam Poh Jeann, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Heng Fook Yew, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Ahmad Naufal Md Alwi, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Tan Li Mei, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Tang Seng Paul, University of Malaya (UM) (Post Graduate Student)
    • Acute radiation related oral toxicities in HNSCC patients in UMMC: A prospective study, Kumutha, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Tan Li Mei, University of Malaya (UM) (Post Graduate Student)
    • Palliative radiotherapy for advanced cancer: Are we giving it to the right patient at the right time?, Syadwa, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Syadwa, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Rosdiana, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Eng Jie Yi, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Mohd Asyraf, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Puvaneswarry, University of Malaya (UM) (Post Graduate Student)
    • Timing And Outcome Of Palliative Chemotherapy, Teh Hooi Lay, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Aldrin Jasper, University of Malaya (UM) (Post Graduate Student)
    • Chemoport usage and complication rates in UMMC., Heng Fook Yew, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Sangeeta, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Patricia Shamani, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Kumutha, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Lee Dai Wee, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, hadi, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Lee Hong Moi, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Ngu Ming Ruey, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Teh Hooi Lay, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, lavannia, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, chan ming jun, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, syafirin, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Fiona, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Vance Koi, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Nisha Mohd Shariff, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Noor Nabila Mohamed, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Lee Hong Moi, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Kumutha a/p Chalaya, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Rosdiana Abd Rahim, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Hadi Jalil, University of Malaya (UM) (Post Graduate Student)
    • Chemoport usage and its complications in the oncology dept, UMMC, Heng Fook Yew, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Syazni Badrol Hisham, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nur Jihan Irwan Tan, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nik Rozlin Elini Mohd Shuhaimi, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Sow We Jen, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Tan Li Mei, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Noor Zafifah Zakaria, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Fiona Suling Lian, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Choong Swee Hsia, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Khairiyah Sidek, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Lim Yaeh Ni, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Lim Yi Way, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Shadwa, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Teo Yin Keong, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Prathepamalar Yehgambaram, University of Malaya (UM) (Post Graduate Student)
    • Timing and outcome of palliative radiotherapy., Syadwa, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Tan Chih Kiang, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Arnil George Sirimanne, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Ng Boon Huat, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Ina Shaliny Duraisamy, University of Malaya (UM) (Post Graduate Student)
    • Clinical Supervision, Santhi Nadarajan, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Winnie Ng Nyek Ping, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Soma Bavani Sivaraj, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Alagu Manthiram Ramasamy, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Nisha Mohd Shariff, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Gan Ben Jin, University of Malaya (UM) (Post Graduate Student)
    • Comparison of dosimetric coverage of RTOG and ESTRO-defined target volumes for chest wall and supraclavicular fossa radiotherapy with standard field-based radiotherapy in University Malaya Medical Centre., Chiam Poh Jeann, University of Malaya (UM) (Post Graduate Student)
    Other
    • clinical supervision, Ravivarma Prathapan, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Astrid Sinarti Hassan, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Narendran K, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Yang Rashidi Abdullah, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Chandra Kumar A/l Krishnan, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Noor Syuhadah A. Karim, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Atiliana Mohamed Adib, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Adlan Suhaimi Ahmad, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Tan Boon Seang, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Farah Zaffar Hayat, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Siti Zaleha Md Sani, University of Malaya (UM) (Post Graduate Student)
    • Clinical supevision, Ng Poh Huat, University of Malaya (UM) (Post Graduate Student)
    • clinical supervision, Felix Liau Yee Fan, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Sunitha Kumaran, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Noorzulali Haron, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Han Albert Dicken, University of Malaya (UM) (Post Graduate Student)
    Completed
    • Clinical supervision, Hafizah Zaharah Ahmad, University of Malaya (UM) (Post Graduate Student)
    • Cinical supervision, Kua Voon Fong, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Leong Siew Mooi, University of Malaya (UM) (Post Graduate Student)
    • PROSPECTIVE EVALUATION OF RADIATION-INDUCED LATE TOXICITIES IN HEAD AND NECK CANCERS IN UNIVERSITY MALAYA MEDICAL CENTRE, Nurhidayu Salimin, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Vaishnavi Jeyasingam, University of Malaya (UM) (Post Graduate Student)
    • adjuvant trastuzumab in early breast cancer: a`retrospective cohort study in two oncology centres in malaysia, Harissa Husainy Hasbullah, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Fong Chin Heng, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Sucharit Pongprakyun, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Muthukumaran, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Wan Zamaniah Wan Ishak, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Ros Suzanna Ahmad Bustamam, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Eznal Izwadi Mohd Mahidin, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Ang Tick Suan, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Suhana Yusak, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Ibtisam Muhammad Nur, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Cheah Soon Keat, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Hayani Abdul Wahid, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Yu Kong Leong, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Lau Kah Liew, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Malwinder Singh Sandhu, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Flora Chong Li Tze, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Marfuah Nik Eezamuddeen, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Nahjatul Kursyiah Abd Ghafar, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Wong Yoke Fui, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Junie Khoo Yu Yen, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Tang Weng Heng, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Rozita Abdul Malik, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Azura Deniel, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Fabian Lee Wei Yuen, University of Malaya (UM) (Post Graduate Student)
    • In vivo skin dose assessment for breast cancer dring radiotherapy treatment using gafchromic film (EBT) detector, Mahzom Pawanchek, University of Malaya (UM) (Post Graduate Student)
    • Dosimetric comparison of the Enhanced Dynamic Wedge and the Physical Wedge and its clinical implications, Mohd Azhar Musa, University of Malaya (UM) (Post Graduate Student)
    • Proteomic studies in patients with NPC: lectin-based approach, Ramarao a/l Seriramalu, University of Malaya (UM) (Post Graduate Student)
    • Assessment of patients with carcinoma of the cervix treated with definitive radiotherapy at UMMC., Si Lay Khaing, University of Malaya (UM) (Post Graduate Student)
    • Concurrent chemoradiation for patients with nasopharyngeal carcinoma treated in UMMC between 2001 and 2003., Nik Muhd Aslan Abdullah, University of Malaya (UM) (Post Graduate Student)
    • The evolution of 2-D to 3-D radiation therapy practice in the treatment of nasopharyngeal carcinoma., Sin Sze Yarn, A0800108 (Post Graduate Student)
    • The Establishment of In-vitro Standard Dose Calibration Curve with High Energy X-ray and Measurement of The Equivalent Dose In Cancer Patients Treated with Radiotherapy Using Biological Dosimetry Technique, Halim Abdul Rahman, University of Malaya (UM) (Post Graduate Student)
    • Analysis of breast cancer in elderly women:cohort of 1994-2004 treated in UMMC, Vincent Phua Chee Ee, University of Malaya (UM) (Post Graduate Student)
    • Symptoms prevalence, characteristics and coping strategies among adult oncology patients., Nor Aziyan Yahya, University of Malaya (UM) (Post Graduate Student)
    • Radiation-induced hypothyroidism following radical radiotherapy for head and neck cancer, Lim Chun Sen, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Harissa Husainy Hasbullah, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Natasha Mohd Hashim, University of Malaya (UM) (Post Graduate Student)
    • Concurrent chemoradiotherapy in H&N cancer, Mastura Md Yusuf, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Lee Wei Ching, University of Malaya (UM) (Post Graduate Student)
    • Clinical supervision, Chan Wee Han, University of Malaya (UM) (Post Graduate Student)
    Undergraduate Student
    (Title of Thesis),(Academic Session)
    Completed
    • Describing the clinical management and resource use of solid tumour patients with chemotherapy-related febrile neutropenia in UMMC, 2012/2013
    PATENT/IPR
    (Product Name),(Type),(Level)
    • Master of Clinical Oncology Programme Syllabus, literary work (University)
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Organiser of IAEA RAS6086 Regional training Course on Multimodality treatment in palliative radiotherapy, 22/03/2021 to 25/02/2021
    • SEAROG Council Advisor, 01/01/2019 to 31/12/2019
    • FARO Council member representing Malaysian Oncological Society and Malaysia, 01/01/2019 to 31/12/2019
    • Breast cancer public forum, 18/10/2014 to 18/10/2014
    • SMK Seksyen 9 Shah Alam Niners A+ committee member, 01/07/2013 to 12/10/2013
    • Women's Integration Society, 2021
    ACADEMIC/PROFESSIONAL SERVICES
    Academic/Professional Services
    (Contribution),(Duration),(Level),(Role)
  • Chair of Faro Education and Training Committee, 01/06/2021 to 31/12/2022, International, (Resource Person)
  • National Project Coordinator for Iaea Project Ras6086, 01/01/2021 to 31/12/2021, International, (Technical Advisor)
  • Evaluation Activity
    (Activity),(Duration),(Category)
  • Development of real-time radioluminescent dosimetry system for medical application , 2021 to 2021 (PhD Proposal defence)
  • Tretament outcome for local recurrent nasopharyngeal carcinoma in UMMCfrom 2010-2017, 2021 to 2021 (Thesis)
  • part 1, 2 and Final Examinations Master of Clinical Oncology May 2021, 2021 to 2021 (Marking exam script/conduct viva voce)
  • Evaluate proposal defense by MSc candidate- Lee Yi Lin (17219644), 2020 to 2020 (masters proposal defense)
  • Examiner for OSCE, 2020 to 2020 (UMMP exam)
  • MAGNITUDE AND FACTORS ASSOCIATED WITH THROMBOSIS AMONG CANCER PATIENTS RECEIVING CHEMOTHERAPY AT OCEAN ROAD CANCER INSTITUTE. , 2020 to 2020 (Article in Journal)
  • Examiner for part 1, part 2 and Final exam for Master of clinical Oncology, 2020 to 2020 (Clinical masters exam)
  • IMPACT OF PHYSICAL ACTIVITY ON PROGNOSIS AND QUALITY OF LIFE OF BREAST CANCER PATIENTS IN MyBCC STUDY , 2020 to 2020 (Masters research project)
  • Role of vitamin D in preventing colororectal carcinogenesis: Systemayic review, 2020 to 2020 (Article in Journal)
  • Mutation profile of breast cancer in Malaysian patients, 2020 to 2020 (Article in Journal)
  • Treatment outcome of brain metastases in UMMC. , 2019 to 2019 (Thesis)
  • Exam script marker, 2019 to 2019 (Master of Clinical Oncology Part 1 exam)
  • All Trans Retinoic Acid (ATRA) Inhibits Telomerase Expression of BeWo Choriocarcinoma Cell (ATCC CCL-98) , 2019 to 2019 (Article in Journal)
  • Logbook and continuous assessment, 2019 to 2019 (Final Exam Master of Clinical Oncology)
  • Marking Part 2 COQ exam scripts. Examiner for Final Examination , 2019 to 2019 (Master of Clinical Oncology Exam)
  • Jawatankuasa Pemeriksa bagi Peperiksaan ljazah Sarjana Sains Perubatan secara Penyelidikan /Kursus dan Penyelidikan (bagi komponen penyelidikan) i)Berkaitan dengan peperiksaan disertasi, menimbang laporan pemeriksa di atas disertasi seorang calon dan mengambil sesuatu keputusan termasuk mengenai tahap pencapaian disertasi itu ; ii) Dalam keadaan tertentu Jawatankuasa Pemeriksa boleh menjalankan peperiksaan viva dan / atau ujian lain difikirkan sesuai ; dan iii) Melaporkan kepada Senat mengenai apa-apa perkara yang berkaitan dengan mutu dan/atau perjalanan sesuatu peperiksaan., 2019 to 2019 (Thesis)
  • Intracranial angiomatoid Fibrous histiocytoma with Hodgkin lymphoma , 2018 to 2018 (Article in Journal)
  • The Great Masquerade: Empyema Thoracis as an Unusual Presentation of Primary Lung Malignancy , 2018 to 2018 (Article in Journal)
  • Comparison of the seventh and eight editions of the UICC/AJCC staging system for NPC; analysis of 1317 patients treated with IMRT at two centres , 2017 to 2017 (Article in Journal)
  • Review and select abstracts for FARO 2017 scientific meeting, 2017 to 2017 (Abstracts)
  • Outcome of patients with cord compression treated in UMMC. Master of Clinical Oncology Final Exam, 2017 to 2017 (Thesis)
  • Marking MCO Part 1 exam scripts , 2017 to 2017 (Exam script)
  • Chemotherapy for metastatic colon cancer -No effect on survival when the dose is reduced due to side-effects. BMC cancer , 2017 to 2017 (Article in Journal)
  • Ref.: Ms. No. MJM-D-17-00148 Breast Ductal Carcinoma to Metaplastic Carcinoma- A Change in Cancer Morphology - A Case Report and Literature Review The Medical Journal of Malaysia , 2017 to 2017 (Article in Journal)
  • "Stress levels during the journey of cancer treatment" , 2017 to 2017 (Article in Journal)
  • Lapatinib, trastuzumab and Capecitabine prolonged the survival of HER2-positive gastric cancer with leptomeningeal carcinomatosis: a case report., 2017 to 2017 (Article in Journal)
  • Examiner for MD degree. Title of thesis: Management of psychological distress in cancer patients. MHB130001, 2017 to 2017 (Thesis)
  • Marking of exam scripts for Master of Clinical Oncology Part 1 May 2017 Exam, 2017 to 2017 (Exam script marker)
  • Evaluation of research proposal under FRGS grant application, 2017 to 2017 (FRGS grant)
  • Relapsed Lymphoma Mimicking Venous Ulcer : A Case report for MJM, 2017 to 2017 (Article in Journal)
  • Peperiksaan OSCE Stage 2 MBBS - RSA 1, 2017 to 2017 (OSCE stage 2 MBBS exam)
  • Review research abstracts submitted for FARO 2016. Provide scoring for each as per guideline from organising commitee., 2016 to 2016 (Abstracts)
  • Pretreatment Expression of Blood and Tissue Biomarkers as a Predictor of Tumor Response After Neoadjuvant Chemoradiation in Rectal Cancer, 2016 to 2016 (Article in Journal)
  • Evaluate the suitability of the following article for publication in BMC Cancer journal: Chemotherapy on metastatic colon cancer:No effect on survival when dose is reduced due to side-effects., 2016 (Article in Journal)
  • Medical Journal Malaysia: Gastric ulcer than turned out to be metastasis of a synovial sarcoma: A case report and literature review., 2016 (Article in Journal)
  • Management of psychological distress in cancer patients: Focus on brief mindful therapy, 2016 (PhD seminar proposal)
  • Chemotherapy Induced Neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort Study, 2016 (Article in Journal)
  • Evaluate suitability of research proposal/project for consideration of sciencefund (MOSTI) research grant, 2016 (Project)
  • Triple negative breast cancer survival and prognostic factors., 2016 (Thesis)
  • Master of Clinical Oncology Part 1, 2 and Final Exams , 2016 (Prepare exam questions and mark exam scripts)
  • Treatment Of heavily pre-treated metastatic breast cancer with Eribulin: First local experience in Sabah. , 2016 (Article in Journal)
  • marking exam scripts and viva voce , 2015 (master of clinical oncology)
  • Palliative to curative treatment: A case of stage 4 mucinous adenocarcinoma successfully treated with metronomic capecitabine in combination with bevacizumab and surgery., 2015 to 2015 (Article in Journal)
  • Symptoms burden and QoL. Comparison between CAM and non-CAM users during breast cancer chemotherapy in 2 public hospitals in Malaysia., 2015 to 2015 (Thesis)
  • Editorial board member for International Journal of Recent Research in Life Sciences (IJRRLS), 2014 (Article in Journal)
  • MJM Chemotherapy extravasation at Hospital Pulau Pinang Malaysia , 2013 to 2013 (Article reviewer)
  • Survival of primary lung cancer patients treated in Brunei darussalam , 2013 to 2013 (External Examiner)
  • The treatment outcome of radical radiotherapy in laryngeal cancer. , 2013 to 2013 (Article reviewer)
  • Metastatic melanoma to the stomach; a case report , 2013 to 2013 (Article reviewer)
  • JUMMEC Case study: Squinting eyes: A presenting complaint in a young adult with glioblastome multiforme. , 2013 to 2013 (Article reviewer)
  • Master of Clinical Oncology Part 1,2 and Final Exam , 2013 (Mark exam scripts and conduct clinical exam)
  • Appointed as external assessor from UCSI University to assess suitability of an academic staff from UCSI for promotion from assoc. prof. to full prof. , 2013 to 2013 (To assess suitability of candidate for promotion )
  • MEASUREMENT OF BLADDER VOLUME VARIATIONS USING PORTABLE ULTRASOUND EQUIPMENT: INTRODUCTION OF DRINKING PROTOCOL , 2013 to 2013 (Article in Journal)
  • Association of creatinine clearance with neutropenia in breast cancer patients undergoing chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide (FAC), 2012 to 2012 (Article in Journal)
  • Induction chemotherapy with paclitaxel, ifosfamide and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer., 2009 to 2009 (Article in Journal)
  • Medulloblastoma: Cranial spinal junctional techniques., 2008 to 2008 (Article reviewer)
  • Poster presentations, 2008 to 2008 (Judge for poster presentations)
  • Advanced Diploma in Nursing Oncology (UM), 2008 to 2008 (Programme evaluator)
  • Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM), 2008 to 2008 (Academic Programme Evaluator)
  • Master of Clinical Oncology Part 1 Exam, 2006 (Internal Examiner)
  • Academic/Technical Contribution
    (Activity),(Organisation),(Duration),(Role)
  • National Project Coordinator forRCA/IAEA RAS6086 project, IAEA, 2019 - 2019 (Coordinator)
  • RCA-IAEA project RAS6086 - Strengthening cancer management programmes in RCA states parties through collaboration with national and regional radiation oncology societies., IAEA, 2018 - 2018 (Coordinator)
  • Evaluate the suitability of eribulin in patients who have failed one line of chemo in the advanced metastatic setting., Drug Control Authority, MOH Malaysia, 2018 - 2018 (Expert Advisor)
  • Evaluate the suitability of TS-1 tablet in terms of bioequivalence as compared to TS-1 capsule to be used for the same clinical indications., DCA, MOH, 2017 - 2017 (Expert Advisor)
  • Evaluate the suitability of cyramza in the treatment of stomach/GOJ tumours, colorectal and NSCLC for the purpose of registration., National Pharmaceutical Control Bureau, MOH Malaysia , 2016 - 2016 (Expert Advisor)
  • Evaluate the suitability of tegafur in the treatment of colorectal cancer for the purpose of additional indication approval., Drug Control Authority Ministry of Health Malaysia, 2016 - 2016 (Expert Advisor)
  • Evaluate the suitability of afinitor in the treatment of advanced renal cell carcinoma in patients with disease progression following treatment with anti VEGF, Drug Control Authority, Ministry of Health, Malaysia, 2016 - 2016 (Expert Advisor)
  • Evaluate the suitability of tegafur in the treatment of pancreatic cancer for the purpose of additional indication approval., Drug Control Authority Ministry of Health Malaysia, 2016 - 2016 (Expert Advisor)
  • Evaluate the suitability of tegafur in the treatment of NSCLC for the purpose of additional indication approval., Drug Control Authority Ministry of Health Malaysia, 2016 - 2016 (Expert Advisor)
  • Evaluate suitability of research project/proposal for consideration of sciencefund(MOSTO) research grant, Universiti Malaya, 2016 - 2016 (Evaluator)
  • Evaluate suitability of nindetanib esilate in advanced NSCLC for the purpose of new drug registration., Pihak Berkuasa Kawalan Dadah Biro Pengawalan Farmaseutikal Kebangsaan Kementerian Kesihatan Malaysia , 2015 - 2015 (Expert Advisor)
  • Evaluate suitability of vismodegib in advanced basal cell carcinoma for the purpose of new drug registration., Pihak Berkuasa Kawalan Dadah Biro Pengawalan Farmaseutikal Kebangsaan Kementerian Kesihatan Malaysia, 2015 - 2015 (Expert Advisor)
  • Root cause analysis, UMMC, 2013 - 2013 (Committee Member)
  • Penilaian ubat-ubatan kimoterapi, Pusat perubatab Universiti Malaya, 2012 - 2012 (Committee Member)
  • Radiation oncology curriculum in developing countries, IAEA, 2012 - 2012 (Consultant )
  • Clinical Oncology Specialty Committee, Universiti Malaya , 2009 - present (Chairman)
  • Organising Committee for APCC 2011, Malaysian Oncological Society, 2008 - present (Committee Member)
  • International Atomic Energy Agency (IAEA) Project Coordinator for project RCA RAS 6040 Improvement in Quality of Radiotherapy for Frequent Cancers in the Region., IAEA , 2005 - 2009 (Coordinator)
  • To give input with regards to the conduct and management of clinical trials and in particular industry sponsored trials managed by Clinical Investigation Centre, UM, Clinical Investigation Centre, Faculty of Medicine , UM , 2005 - Present (Committee Member)
  • Structuring, data collection, analysis and report writing, National Cancer Registry, 2003 - 2007 (Advisor)
  • Medical Advisory Committee member. Advise on clinical issues at UMMC., UMMC, 2001 - Present (Committee Member)
  • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • Certifcate of Appreciation, FARO, 2019
    • Certificate of appreciation, Faculty of Medicine,UM, 2019
    • Appreciation letter, FARO 2018 organising committee, 2018
    • Live surgery IORT workshop, College of Surgeons and Academy of Medicine Malaysia, 2017
    • Certificate of appreciation, UMMC, 2017
    • Letter of appreciation, Universiti Malaya, 2016
    • Certificate of appreciation, MASPHO, 2016
    • Certificate of Appreciation, Malaysian Psychiatric Association, 2016
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2014
    • Appreciation, UMMC, 2014
    • KHIDMAT SETIA 20 AWARD, , 2013
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2012
    • Appreciation, IAEA, 2012
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2012
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2009
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2009
    • Eskpo Penyelidikan, Rekacipta dan Inovasi UM 2009, Universiti Malaya, 2009
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2007
    • Appreciation, Dept of Biomedical Imaging, UMMC, 2007
    • Appreciation, National cancer registry, 2007
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2006
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2006
    • Bronze medal for the category of Fundamental Research: Oxidative stress biomarkers in breast cancer. Eskpo Penyelidikan, Rekacipta dan Inovasi 2006, 18-20 Julai, Universiti Malaya, 2006
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2005
    • Gold medal for the category of Invention & Innovation sempena Eskpo Penyelidikan, Rekacipta dan Inovasi 2005, 14-17 Jun. Oral Cancer Database Software- Real and Virtual Tumor Bank System (OCDS/RVTBS)- An Aid for Multicenter Studies., Universiti Malaya, 2005
    • Appreciation, ministry of health, 2004
    • Appreciation, MITC, UMMC, 2004
    • Appreciation, MOH, 2004
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2003
    • Appreciation, National cancer registry, 2003
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2003
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2002
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2001
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Collaborations of Radiation Oncology in Asia, JASTRO, 01/12/2016 to 01/12/2016 (International)
    • MEASUREMENT OF BLADDER VOLUME VARIATIONS USING PORTABLE ULTRASOUND EQUIPMENT: INTRODUCTION OF DRINKING PROTOCOL , BIIJ, 01/05/2013 to 01/05/2013 (International)
    • Eribulin in breast cancer treatment, Eisai Malaysia Sdn Bhd, 01/04/2013 to 01/04/2013 (National)
    • The treatment outcome of radical radiotherapy in laryngeal cancer, BIIJ, 01/02/2013 to 01/02/2013 (International)
    • Association of creatinine clearance with neutropenia in breast cancer patients undergoing chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide (FAC), MJM, 01/02/2012 to 01/02/2012 (National)
    • Head of panel of judges for oral presentations at ASCOMOS 2012, Malaysian Oncological Society, 01/04/2012 to 01/04/2012 (National)
    • Radiation Oncology training in Malaysia, IAEA, 01/09/2012 to 01/09/2012 (International)
    • Penilaian ubat-ubatan kemoterapi, UMMC, 01/09/2012 to 01/09/2012 (National)
    • Erlotinib in first line EGFR mutation positive NSCLC , Roche, 01/08/2012 to 01/08/2012 (National)
    • Poster presentations MOS 2008, Malaysian Oncological Society, 01/01/2008 to 01/01/2008 (National)
    • MOS Annual Scientific Meeting, Malaysian Oncological Society, 01/01/2001 to 01/01/2001 (National)
    • Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM) , UKM, 01/01/2003 to 01/01/2003 (National)
    • Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM) , UKM, 01/01/2003 to 01/01/2003 (National)
    • Annual Scientific meetings, Malaysian Oncological Society, 01/01/2001 to 01/01/2003 (National)
    • National cancer registry, Ministry of Health, 01/01/2003 to 01/01/2007 (National)
    • 37th Malaysia-Singapore Congress of Medicine, Academy of Medicine, 01/01/2003 to 01/01/2003 (National)
    • Asia Pacific Cancer Conference 2011, Malaysian Oncological Society, 01/05/2008 to 01/05/2011 (International)
    • Medulloblastoma: Cranial spinal junctional techniques., BIIJ, 01/01/2008 to 01/01/2008 (National)
    • Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer, BIIJ, 01/02/2009 to 01/02/2009 (National)
    • Radioimmunotherapy-Based Treatment of Cancer, BIIJ, 01/04/2011 to 01/04/2011 (National)
    • International Atomic Energy Agency (IAEA) Project RCA RAS 6040 Improvement in Quality of Radiotherapy for Frequent Cancers in the Region ., International Atomic Energy Agency (IAEA), 01/01/2005 to 01/01/2009 (International)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    INVITED SPEAKER
  • Acute and late toxicities of systemic therapy, MSCT 2020, 11/09/2020 to 12/09/2020, Clin Oncology Dept, UMMP (National)
  • Immunotherapy in metastatic breast cancer., Immuno-0ncology symposium in conjunction with World cancer research day, 24/09/2019 to 24/09/2019, Department of Surgery, FOM, UM (National)
  • IORT in breast cancer, FARO Annual Meeting 2018, 06/09/2018 to 08/09/2018, Indonesia radiation oncology society (International)
  • Antimetabolites, MSCT 2018, 09/03/2018 to 10/03/2018, Clinical Oncology Dept, UMMC (National)
  • IORT in breast cancer, Live surgery IORT workshop, 24/08/2017 to 25/08/2017, Dept of Surgery, UMMC (International)
  • Antimetabolites, Masterclass in Systemic Cancer Therapy, 04/03/2017 to 05/03/2017, Dept of Clinical Oncology, UMMC (National)
  • RADIATION THERAPY IN NEUROBLASTOMA, MASPHO ASM 2016, 05/11/2016 to 06/11/2016, MASPHO (National)
  • Epidemiology of cancer and current treatment modalities, 20th Malaysian Conference on Psychological Medicine, 03/06/2016 to 03/06/2016, Malaysian Psychiatric Association (National)
  • Development of oncology training in middle income countries: the Malaysian model, AROICON 2015, 29/11/2015 to 29/11/2015, AROI (International)
  • Hormonal therapy in breast cancer, 1st UMMC breast cancer public forum, 18/10/2014 to 18/10/2014, Breast cancer resource centre,UMMC (Others)
  • An overview of cancer services in Malaysia; a virtual tour of Clin Onco Dept UMMC ; Oncology training in Malaysia, Department of Radiation Oncology, Technical University Munich Seminar, 04/04/2014 to 04/04/2014, Department of Radiation Oncology, Technical University Munich (International)
  • Recurrent and metastatic NPC: issues and challenges, NPC research day, 04/03/2013 to 04/03/2013, NPC Society Malaysia/Universiti Malaya (National)
  • Radiotherapy planning for breast cancer, Moving from 2D to 3D conformal radiotherapy workshop IAEA MAL 6020, 20/06/2012 to 22/06/2012, MOH (National)
  • clinical research forum, 5th national conference on clinical research, 24/06/2011 to 24/06/2011, ministry of health malaysia (National)
  • Radiation Therapy for cancer, Seminar perawatan Onkologi, 28/09/2010 to 28/09/2010, PTj Pembangunan Insan (University)
  • Pengenalan Kanser Wanita dan Rawatan, Seminar kanser wanita dari perspektif biopsikososial, 11/11/2008, PTj Kebajikan Perubatan, PPUM (National)
  • Oncology Endpoints: Their relevance in advanced cancer. , Palliative Care Symposium: Clinical Decision making and Ethics in Advanced Cancer, 18/04/2007, Faculty of Medicine, UM (National)
  • An overview of radiation therapy in cancer treatment., A Continuous Professional Development Course in Radiotherapy, 20/12/2005 to 22/12/2005, Radiology Dept., FOM, UM (National)
  • Radiotherapy of BAVM, Basic Neuro-interventional Course, 11/03/2004 to 12/03/2004, Radiology Dept, FOM, UM (University)
  • Follow-up of treated breast cancer patients, MOS Annual Scientific Meeting, 20/09/2002 to 22/09/2002, MOS (National)
  • Hormone therapy, Oncology in Palliative Care Seminar, 29/07/2001, Hospis Malaysia (National)
  • EVENT ORGANISER
  • Not applicable, APCC 2011, 10/11/2011 to 11/11/2011, MOS (International)
  • None, MOS Annual Scientific Meeting, 28/09/2002 to 30/09/2001, MOS (National)
  • POSTER PRESENTER
  • Outcome of malignant CNS tumours in young children from a single institution in Malaysia: 15-year experience with HEAD START 1 and 2 protocols, SIOP 2018, 16/11/2018 to 18/11/2018, SIOP (International)
  • Prospective controlled study on the role of scalp hypothermia to prevent chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy., APCC 2011, 10/11/2011 to 11/11/2011, MOS (International)
  • Psycho-Oncology Referrals- A Single-Centre Review from Malaysia, IPOS 12th World Congress of Psycho-Oncology, 25/05/2010 to 29/05/2010 (International)
  • DEVELOPMENT OF SPECIALIST TRAINING PROGRAMME IN CLINICAL ONCOLOGY: THE MALAYSIA EXPERIENCE, ICARO 2009, 27/04/2009 to 29/04/2009, IAEA (International)
  • PRESENTER
  • Country report, Progress Review Meeting of RAS6086, 25/11/2020 to 26/11/2020, IAEA (International)
  • Covid 19 situation in Malaysia; impact on radiotherapy services, 1st FARO webinar, 25/09/2020 to 25/09/2020, ISRO (International)
  • Clinical Oncology training in Malaysia, 1st FARO Council Member meeting, 30/05/2015 to 30/05/2015, Japan as host country (International)
  • Key Performance Indices , Ministry of Health Workshop on Quality Assurance in Radiotherapy , 01/08/2006, MOH (National)
  • Concurrent chemoradiotherapy for cervical cancer (CERVIX-III), FNCA workshop on Radiation Oncology, 13/12/2004 to 17/12/2004, FNCA (International)
  • OTHERS
  • not applicable, ESMO Penang, 22/01/2015 to 25/01/2015, MOS and ESMO (International)
  • Lung cancer, World conference on lung cancer, 27/10/2013 to 30/10/2013, IASLC (International)
  • Breast cancer, Asia Pacific Breast Cancer Summit, 12/04/2013 to 13/04/2013 (International)
  • Jacob study for stomach cancer, JACOB study Investigator Meeting, 06/03/2013 to 08/03/2013, Roche (International)
  • Oral presentations, ASCOMOS 2012, 08/09/2012 to 08/09/2012, MOS (National)
  • Report on Lung cancer statistics, NCR Report Writing Workshop for year 2003-2005, 02/03/2007 to 04/03/2007, MOH (National)
  • None, 37th Malaysia-Singapore Congress of Medicine, 05/09/2003 to 07/09/2003, Academy of Medicine (National)